NephrosNEPH
NEPH
About: Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
Employees: 31
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0.39% less ownership
Funds ownership: 41.04% [Q2] → 40.65% (-0.39%) [Q3]
6% less funds holding
Funds holding: 18 [Q2] → 17 (-1) [Q3]
20% less capital invested
Capital invested by funds: $9.17M [Q2] → $7.33M (-$1.84M) [Q3]
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
100% less funds holding in top 10
Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$5
225%
upside
Avg. target
$5
225%
upside
High target
$5
225%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Benchmark Robert Wasserman 55% 1-year accuracy 27 / 49 met price target | 225%upside $5 | Speculative Buy Reiterated | 12 Nov 2024 |
Financial journalist opinion
Neutral
GlobeNewsWire
2 weeks ago
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be participating in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference. The event is scheduled for Wednesday, December 11, 2024, at the New York Athletic Club in New York City.
Neutral
Seeking Alpha
1 month ago
Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript
Nephros, Inc. (NASDAQ:NEPH ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - President & Chief Executive Officer Judy Krandel - Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group Ralph Weil - R. Weil Investment Management Operator Good day, and welcome to the Nephros Inc. Third Quarter 2024 Financial Results Conference Call.
Neutral
GlobeNewsWire
1 month ago
Nephros Schedules Third Quarter 2024 Financial Results Conference Call
SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its third-quarter financial results on Thursday, November 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.
Neutral
GlobeNewsWire
2 months ago
Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which devastated parts of the southeastern United States. Leveraging its significant disaster and emergency response capabilities, Nephros provided crucial water filtration solutions to multiple healthcare and nursing care facilities affected by the storms, ensuring a safe supply of water to patients and staff amid recovery efforts.
Neutral
Seeking Alpha
4 months ago
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
4 months ago
Nephros Announces Financial Results for Quarter Ended June 30, 2024
Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2024. Financial Highlights* Net revenue of $3.3 million, a decrease of 8% over Q2 prior year; programmatic revenue (excluding emergency response revenue) increased 8% over Q2 prior year Net loss of $0.3 million, compared to a net loss of $0.4 million Adjusted EBITDA of ($133,000), compared to ($183,000) *Stated performance is relative to same period in the prior year unless otherwise noted.
Neutral
GlobeNewsWire
4 months ago
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 8, 2024 after market close and will host a conference call that same day at 4:30pm ET.
Neutral
Seeking Alpha
9 months ago
Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript
Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ET
Neutral
GlobeNewsWire
9 months ago
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. Financial Highlights Fourth Quarter Ended December 31, 2023 Net revenue from continuing operations was $3.3 million, compared to $2.6 million in the fourth quarter of 2022, up 27% Net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2022 Adjusted EBITDA from continuing operations was ($0.1 million), compared to ($0.5 million) in the fourth quarter of 2022, an improvement of 89% Year-End 2023 Net revenue from continuing operations was $14.2 million, compared with $10.0 million in 2022, up 43% Net loss from continuing operations was ($1.6 million), compared with ($4.3 million) in 2022 Adjusted EBITDA from continuing operations was ($0.1 million), compared with ($2.4 million) in 2022, an improvement of 97% “2023 was an exciting year for Nephros.
Neutral
GlobeNewsWire
9 months ago
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.
Charts implemented using Lightweight Charts™